These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33363346)

  • 1. Comparative safety and efficacy of two bivalent vaccines containing Newcastle disease LaSota and avian influenza H9N2 Sidrap isolate formulated with different oil adjuvants.
    Cahyani JI; Widyarini S; Wibowo MH
    Vet World; 2020 Nov; 13(11):2493-2501. PubMed ID: 33363346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of combined trivalent inactivated ISA 71 oil adjuvant vaccine against avian influenza virus subtypes (H9N2 and H5N1) and Newcastle disease virus.
    Ali ZM; Hassan MAEM; Hussein HA; Ahmed BM; Sanousi AAEE
    Vet World; 2017 Oct; 10(10):1212-1220. PubMed ID: 29184367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.
    Lee DH; Park JK; Kwon JH; Yuk SS; Erdene-Ochir TO; Jang YH; Seong BL; Lee JB; Park SY; Choi IS; Song CS
    PLoS One; 2013; 8(3):e58186. PubMed ID: 23469269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequence of Cryptosporidiosis on the immune response of vaccinated broiler chickens against Newcastle disease and/or avian influenza.
    Eladl AH; Hamed HR; Khalil MR
    Vet Res Commun; 2014 Sep; 38(3):237-47. PubMed ID: 24993748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Study on the Efficacy of MF 59, ISA70 VG, and Nano-Aluminum Hydroxide Adjuvants, Alone and with Nano-Selenium on Humoral Immunity Induced by a Bivalent Newcastle+Avian Influenza Vaccine in Chickens.
    Radmehri M; Talebi A; Ameghi Roudsari A; Mousaviyan SM; Gholipour MAJ; Taghizadeh M
    Arch Razi Inst; 2021 Nov; 76(5):1213-1220. PubMed ID: 35355760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of mucosal nanoparticles and polymer-based inactivated vaccine for Newcastle disease and H9N2 AI viruses.
    Naggar HM; Madkour MS; Hussein HA
    Vet World; 2017 Feb; 10(2):187-193. PubMed ID: 28344402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens.
    Jafari M; Moghaddam Pour M; Taghizadeh M; Masoudi S; Bayat Z
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):84-89. PubMed ID: 26757848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
    Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of Newcastle disease - avian influenza bivalent vector vaccines in commercial chickens.
    Wu Q; Wei L; Du X; Sun W; Li S; Guo X; Jiang M; Liu J; Xue Z; Li H; Zhang T; Wang W; Ren G
    Int Immunopharmacol; 2023 Jul; 120():110363. PubMed ID: 37245299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of Spirulina extract on pathogenicity, immune response, and vaccine efficacy against H9N2 avian influenza virus in specific pathogen free chickens.
    Yehia N; Mohamed FH; Al-Zaban MI; Amer F; Baazaoui N; Khattab MS; Abd Elhalem Mohamed A; Salem HM; El-Saadony MT; El-Tarabily KA; Omar DM
    Poult Sci; 2024 Jan; 103(1):103194. PubMed ID: 38041892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trials for preparation and evaluation of a combined inactivated reassorted H5N1 and
    Sayed MFE; Soliman RA; Ghanem HM; Khedr MMS; Mohamed GM; Safty MMDE
    Vet World; 2021 Jun; 14(6):1677-1681. PubMed ID: 34316218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAvant® WO-60 as an Effective Immunological Adjuvant for Avian Influenza and Newcastle Disease Vaccine.
    Lee ES; Shim YJ; Chathuranga WAG; Ahn YH; Yoon IJ; Yoo SS; Lee JS
    Front Vet Sci; 2021; 8():730700. PubMed ID: 34926633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined H5ND inactivated vaccine protects chickens against challenge by different clades of highly pathogenic avian influenza viruses subtype H5 and virulent Newcastle disease virus.
    Ali A; Safwat M; Kilany WH; Nagy A; Shehata AA; El-Abideen MAZ; Dahshan AM; Arafa AA
    Vet World; 2019 Jan; 12(1):97-105. PubMed ID: 30936661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved immune responses to a bivalent vaccine of Newcastle disease and avian influenza in chickens by ginseng stem-leaf saponins.
    Yu J; Shi FS; Hu S
    Vet Immunol Immunopathol; 2015 Oct; 167(3-4):147-55. PubMed ID: 26277227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
    Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between avian influenza subtype H9N2 and Newcastle disease virus vaccine strain (LaSota) in chickens.
    Ellakany HF; Gado AR; Elbestawy AR; Abd El-Hamid HS; Hafez HM; Abd El-Hack ME; Swelum AA; Al-Owaimer A; Saadeldin IM
    BMC Vet Res; 2018 Nov; 14(1):358. PubMed ID: 30458777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.